Skip to content

Dexmedetomidine vs Fentanyl in Controlling Labor Pain

Dexmedetomidine Versus Fentanyl as an Adjuvant to Single Low Dose Spinal Anesthesia in Controlling Labor Pain: a Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06392321
Enrollment
90
Registered
2024-04-30
Start date
2023-04-01
Completion date
2023-12-31
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Keywords

Dexmedetomidine, Fentanyl, intrathecal, labor pain

Brief summary

As most woman experience agonizing pain throughout vaginal labor. Adjuvants were added to intrathecal bupivacaine aiming to improve the quality of analgesia. This study aimed to assess the efficacy and outcome of intrathecal dexmedetomidine and fentanyl in controlling pain during delivery.

Detailed description

Throughout vaginal deliveries, many women suffered from pain. providing suitable analgesia is crucial (Lupu et al., 2023). Spinal anesthesia can provide pain management (Parikh et al., 2018). Various types of analgesics can be combined to get the needed duration of perioperative analgesia. Dexmedetomidine has been used with effective pain management outcomes (Shrestha et al., 2023). Fentanyl can help pain relief in short duration procedures (Show et al., 2022).

Interventions

DRUGFentanyl

comparison between bupivacaine, bupivacaine and fentanyl.

DRUGDexmedetomidine

comparison between bupivacaine, bupivacaine and dexmedetomidine..

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* women planned for spontaneous vaginal delivery.

Exclusion criteria

* cardiac, liver or kidney disease, allergy to local anesthetics or the studied drugs, any contraindication of regional anesthesia and intrauterine growth retardation or fetal compromise.

Design outcomes

Primary

MeasureTime frameDescription
efficacy of intrathecal dexmedetomidine120 minutesVAS

Secondary

MeasureTime frameDescription
patient satisfaction2 hourssatisfaction score
mother's outocme1 and 5 minutesAPGAR

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026